ArticleBMC nephrology2024

Comparations of efficacy and safety of rituximab, calcineurin inhibitors and cyclophosphamide in primary membranous nephropathy: a single-center retrospective analysis.

Luying Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.